HIPRA NORDIC ApS: Financial statements 2023
CVR: 35407464
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
HIPRA NORDIC ApS (CVR 35407464) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 14,660,742 and a net result of DKK 2,640,474 compared with DKK 2,567,660 the year before. That is an increase of 4.8% compared with the year before. Equity in the 2023 report amounted to DKK 17,839,664. The solvency ratio was 85.1%. The company had 12 employees in the financial year.
- Gross Profit
- DKK 14,660,742
- Profit/Loss
- DKK 2,640,474
- Equity
- DKK 17,839,664
- Total Assets
- DKK 20,967,549
- Employees
- 12
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 14.7 mio. | 2.6 mio. | 17.8 mio. | 12 |
| 2022 | - | 14 mio. | 2.6 mio. | 15.2 mio. | 11 |
| 2021 | - | 13.9 mio. | 2.7 mio. | 12.6 mio. | 11 |
| 2020 | - | 10.9 mio. | 1.6 mio. | 10 mio. | 10 |
| 2019 | - | 10.3 mio. | 1.6 mio. | 8.4 mio. | 8 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
HIPRA NORDIC ApS has published its annual report for 2022. Gross profit came to DKK 13,987,059, and the net result was DKK 2,567,660.
About HIPRA NORDIC ApS
HIPRA NORDIC ApS is a Danish company of the type Anpartsselskab based in Vejen, founded in 2013. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named HIPRA DANMARK ApS. The management consists of David Caballero Tomás, Maria Del Mar Nogareda Estivill and Peter Cyriel A.Saey. The company is owned by Laboratorios Hipra, S.A.. The company has 8 employees (2026). In 2025, the company reported a gross profit of DKK 18,263,321 and a net result of DKK 4,530,928 compared with DKK 3,801,334 the year before. Equity in the 2025 report amounted to DKK 26,171,926.